Clinical Trials Logo

Filter by:
NCT ID: NCT04552834 Active, not recruiting - Critical Illness Clinical Trials

Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes

Start date: September 15, 2020
Phase:
Study type: Observational

This study is designed to study the variations in the microbiome among critically ill patients and the effect of admission to the medical intensive care unit (MICU) at the University of Chicago. Additionally, investigators will examine the downstream clinical effects of dysbiosis in ICU patients and how patients maybe effected long term.

NCT ID: NCT04552795 Active, not recruiting - Clinical trials for Alzheimer Disease, Early Onset

Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease

ART-AD
Start date: February 15, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of the study is to evaluate the ability of (-)-L-2',3'-dideoxy-3'-thiacytidine (3TC) to engage its intended target, penetrate the central nervous system (CNS), suppress neurodegeneration, and assess safety and tolerability in patients with early stage Alzheimer's disease. This study will provide the initial data on target engagement and Alzheimer's disease-relevant outcomes for future trials.

NCT ID: NCT04552769 Active, not recruiting - Thyroid Cancer Clinical Trials

Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Start date: September 10, 2020
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the efficacy of treatment with abemaciclib in patients with anaplastic thyroid/undifferentiated thyroid

NCT ID: NCT04552288 Active, not recruiting - Solid Tumor Clinical Trials

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Start date: September 16, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out whether the study drug benralizumab is a safe treatment that can reduce the skin side effects caused by cancer treatment by reducing the level of eosinophils in your blood. Reducing the skin side effects of your cancer treatment may improve quality of life and allow participants to continue to receive their usual cancer treatment.

NCT ID: NCT04552223 Active, not recruiting - Clinical trials for Metastatic Uveal Melanoma

Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

Start date: November 10, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this research is to test if a combination treatment of nivolumab and relatlimab will result in tumor reduction in patients with metastatic uveal melanoma.

NCT ID: NCT04552119 Active, not recruiting - Rotator Cuff Clinical Trials

Safety of Treatment of Shoulder Repair

HEALICOIL_KNTL
Start date: December 30, 2020
Phase:
Study type: Observational

This study evaluates the safety of the HEALICOIL Knotless Suture Anchors in patients requiring a repair of the rotator cuff tendon repair

NCT ID: NCT04551469 Active, not recruiting - Cardiac Surgery Clinical Trials

A Randomized Clinical Trial to Measure Efficacy of Music on Cardiac Surgery Patients

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

Cardiac surgery involves both physical and psychological stress for patients from time of decision to the recovery period. The physical aspects and the impact on the psychological experience makes the post-operative period a difficult time for patients. Patients often experience emotional distress, uncertainty, and fear. A non-pharmacological intervention of music may affect the patient's perception of early recovery with little to no side effects. Current research has demonstrated efficacy in psychological and physical responses. there is limited data on the endocrinologic (cortisol) and immunologic biomarkers Immunoglobulin A to a music intervention. Therefore, the purpose of this study is to measure both psychological/physical response and biomarkers pre and post a 30-minute music intervention compared to standard of care experience A randomized, placebo-controlled, pre-post clinical trial will be initiated to demonstrate the effect that music has on the primary outcome of serum cortisol and secondary outcomes of anxiety, pain, blood pressure, heart rate, respirations, and Immunoglobulin A in adult patients after cardiac surgery.

NCT ID: NCT04551430 Active, not recruiting - Clinical trials for Metastatic Soft-tissue Sarcoma

Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

Start date: January 5, 2021
Phase: Phase 2
Study type: Interventional

The hypothesis of this study is that the response rate of soft tissue sarcoma will be improved with the addition of PD-1 and CTLA-4 inhibition to cabozantinib, and that cabozantinib priming will increase the response to nivolumab and ipilimumab.

NCT ID: NCT04551066 Active, not recruiting - Myelofibrosis Clinical Trials

To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

Start date: May 27, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the efficacy of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis.

NCT ID: NCT04551053 Active, not recruiting - Myelofibrosis Clinical Trials

To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

Start date: May 26, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the efficacy and safety of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis who have suboptimal response while receiving ruxolitinib monotherapy.